Symbiosis IP ltd

Bronze - Firms: prosecution

Patent prosecution outfit Symbiosis IP receives a relentless stream of positive reports: “The work carried out by Symbiosis has always been of high quality. The team have a wealth of experience and understanding in life sciences, which means they are able to provide advice on patent filing from the earliest stage right through prosecution. Whereas some firms seem obsessed with billing, which leaves the client with the feeling that they will tell you what you want to hear, Symbiosis seem to be the complete opposite – they really give you a grilling to test the strength of your science and data and then give an excellent assessment of the potential for the patent to be granted and the value of said patent.” “Their communications are clear and always in good time for action to be taken. They have established a good network of foreign associates and we have recently had successful filings in the USA, Japan and China without a need for extensive office action and its associated costs. The service provided by Symbiosis is personal, efficient and highly professional.” Its expert team of patent attorneys includes Julie Myint, Mark Hoggins, Lee Samuel and Robert Docherty, each of whom receives individual praise. Myint heads the department: “Julie always asks the right questions and grasps the heart of the invention easily. Julie expresses herself very clearly and it is straightforward to communicate with her, in both written and oral form. She presents commercial strategies, thanks to her long experience in the field and concrete exposure to challenges that she has been able to overcome.” Hoggins, meanwhile, “consistently delivers excellent service and detailed and informed responses to examiners, and helps clients understand each step and grow in their understanding of the IP protection process”, while Samuel “readily understands technology and consistently demonstrates thorough knowledge of patent law, great attention to detail and efficient organisational skills, leading to successful grants”. About Docherty, on the other hand, one source attests: “It is not an exaggeration to state that our confidence in Rob and Symbiosis is such that the strategic direction of our company has been IP-led at all times.”